The Hindu Business Line : Aurobindo Pharma unit gets UK regulator nod

THE Medicines and Healthcare Products Regulatory Agency of the UK has recommended Aurobindo Pharma Ltd's (APL) Unit 3 facility as a site for manufacturing formulations for the UK market.

APL can now foray into regulated markets, starting with Europe. The company has filed several dossiers with European authorities for its APIs and formulations.

APL has also made significant investments to penetrate into Europe, the US, China and Brazil in the last three years.

According to a company release, Unit has already got approvals from South Africa and Brazil, in addition to ISO and approvals from several other countries.

More Stories on : Announcements | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Petronet plans to double capacity at Dahej terminal

Aban Loyd to buy rig from French co Pride

Dredging Corpn appoints PwC for scouting foreign partners

Aurobindo Pharma unit gets UK regulator nod

Emaar Properties to build luxury hotels worldwide

Companies allowed to raise ECBs for overseas investment

`Reliance, IPCL merger likely only after next June'

ONGC Videsh close to buying stake in Angola field

Foskor acquires 5% stake in Godavari Fert

PTC issue to open on March 1

Mukand plans right issue for Rs 51 crore

Ranbaxy gets tentative nod from USFDA for Modafinil

TRL revival plan may see light next month

Reliance may lose Rs 600 cr on lower oil PSUs offtake

Honda Siel plans to increase market share

Toyota to increase output, expand dealer network

Marico focusing on margins than volumes